Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 1 February 2018, 10:00 HKT/SGT
Share:
    

Source: MIMS Singapore
MIMS Announces Growth, Expansion to New Office in Taiwan

SINGAPORE, Feb 1, 2018 - (Media OutReach) - MIMS, a leading multichannel provider of drug information, medical communications and technology solutions in Asia Pacific, is pleased to announce the opening of a new branch office in Taiwan located at 20th floor, No.97, SEC.2, Dun Hua S. Rd., Taipei, Taiwan.

The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry. The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.

"MIMS brings to Taiwan deep expertise in medical communications and strategy," stated Victor Wright, Regional VP of Medical Communications APAC. "MIMS takes pride in bringing exceptional scientific content and events management along with rigorous editorial standards and strict regulatory compliance. It's an exciting opportunity for MIMS to provide best-in-class solutions to the Taiwan pharmaceutical industry."

Prior to the official opening in Taipei, MIMS has offered these services to several multinational pharmaceutical companies in Taiwan.

MIMS has a leading position in the Asia-Pacific healthcare landscape, anchored in its drug reference publications historically. In the past decade, it has evolved to develop progressive digital solutions to empower doctors and healthcare communities to improve patient outcomes.

About MIMS Group

Established in 1963, MIMS is a multichannel provider of drug information, medical education and digital solutions connecting healthcare communities. Our work empowers healthcare communities to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 13 countries (including Taiwan) across Asia Pacific region with approximately two million healthcare professional subscribers to its drug & resource portal, digital and print publications.

Contact:
MIMS Taiwan office address is 20th floor., No. 97, SEC. 2, Dun Hua S. Rd., Taipei, Taiwan. Telephone number: +886 (02) 2709 0611

For more information about the MIMS Taiwan office, please contact Victor Wright at +852 6463-1177, [email protected].


Feb 1, 2018 10:00 HKT/SGT
Topic: Press release summary

http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Leyou Technologies Announces 2019 Interim Results  
Aug 23, 2019 20:19 HKT/SGT
Thailand's Department of Intellectual Property, Ministry of Commerce, AVIA and TrueVisions host Anti-Piracy Summit  
Aug 23, 2019 19:30 HKT/SGT
Hong Kong in Fashion sets the scene for CENTRESTAGE  
Aug 23, 2019 16:30 HKT/SGT
Toyota Provides Diverse Mobility for Tokyo 2020, including a Full Line-up of Electrified Vehicles  
Aug 23, 2019 15:58 HKT/SGT
Huifu Payment Revenue Grew 34%; Digital Transformation Shows Significant Gains  
Aug 23, 2019 15:57 HKT/SGT
Mongolian Mining Corporation announces 2019 Interim Results  
Aug 23, 2019 13:52 HKT/SGT
NEC Receives Order for Intelligent Transportation System in Makkah, Saudi Arabia  
Aug 23, 2019 10:42 HKT/SGT
Paradise Entertainment Limited Reports 2019 Interim Results  
Aug 23, 2019 09:23 HKT/SGT
VCREDIT 1H19 Recorded Significant Revenue Growth 46.4%, Successfully Transformed into a Pure Online Consumer Finance Service Provider  
Aug 23, 2019 09:00 HKT/SGT
Trintech Achieves Record-Breaking New Customer Adoption and Expansion in H1  
Aug 23, 2019 00:30 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: